Autologous Stem Cell Transplant in the Era of Bortezomib-Based Induction for AL Amyloidosis – A Single Institution 11 Year Experience

doi 10.32392/biomed.7
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Knowledge Enterprise Journals

Related search

Risk-Adapted Melphalan and Stem Cell Transplant for Systemic Light Chain Amyloidosis: A Single Institution Experience

Biology of Blood and Marrow Transplantation
TransplantationHematology
2013English

Bortezomib-Based Induction for Transplant Ineligible AL Amyloidosis and Feasibility of Later Transplantation

Bone Marrow Transplantation
TransplantationHematology
2015English

Autologous Stem Cell Mobilization in AL Amyloidosis With Plerixafor and G-Csf: Update of a Single Center Experience

Biology of Blood and Marrow Transplantation
TransplantationHematology
2014English

Combination of Bortezomib in the Induction, Conditioning and Consolidation With Autologous Hematopoietic Stem Cell Transplantation in Patients With Immunoglobulin Light Chain Amyloidosis

American Journal of Hematology
Hematology
2019English

Orthotopic Heart Transplant Facilitated Autologous Hematopoietic Stem Cell Transplantation in Light-Chain Amyloidosis

Biology of Blood and Marrow Transplantation
TransplantationHematology
2012English

Outcomes of Allogeneic Stem Cell Transplant in Patients With Chronic Myelomonocytic Leukemia (CMML) - A Single Institution Experience

Biology of Blood and Marrow Transplantation
TransplantationHematology
2015English

Autologous Stem Cell Transplantation in Multiple Myeloma in the Era of Novel Drug Induction: A Retrospective Single-Center Analysis

Acta Haematologica
MedicineHematology
2017English

Pegfilgrastim in Autologous Stem Cell Transplant

Biology of Blood and Marrow Transplantation
TransplantationHematology
2016English

Treatment With Autologous Stem Cell Transplantation in Multiple Myeloma Patients: A 10-Year Single Centre Experience

Serbian Journal of Experimental and Clinical Research
Medicine
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy